apsisglobal.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: | ||
Meta Tags
| Title | Homepage |
| Description | About us R&D Technologies Investors & Partners Contact us APSIS Therapeutics, INC. is a biopharmaceutical company developing novel molecules for treatment |
| Keywords | apsis therapeutics nucleosides antiviral bcprotide prodrugs |
Server Information
| WebSite | |
| Host IP | 162.241.218.46 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
apsisglobal.com Valuation
|
US$1,274
Last updated: 2023-05-18 03:05:50
apsisglobal.com has Semrush global rank of 0. apsisglobal.com has an estimated worth of US$ 1,274, based on its estimated Ads revenue. apsisglobal.com receives approximately 147 unique visitors each day. Its web server is located in United States, with IP address 162.241.218.46. According to SiteAdvisor, apsisglobal.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,274 |
| Daily Ads Revenue | US$1 |
| Monthly Ads Revenue | US$35 |
| Yearly Ads Revenue | US$423 |
| Daily Unique Visitors | 9 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| apsisglobal.com. | A | 14400 | IP: 162.241.218.46 |
| apsisglobal.com. | NS | 21600 | NS Record: ns1.bluehost.com. |
| apsisglobal.com. | NS | 21600 | NS Record: ns2.bluehost.com. |
| apsisglobal.com. | MX | 14400 | MX Record: 0 mail.apsisglobal.com. |
| apsisglobal.com. | TXT | 14400 | TXT Record: v=spf1 a mx ptr include:bluehost.com ?all |
HtmlToTextCheckTime:2023-05-18 03:05:50
| About us R&D Technologies Investors & Partners Contact us APSIS Therapeutics, INC. is a biopharmaceutical company developing novel molecules for treatment of chronic/relapsing infectious diseases. Our goal is to better peoples lives by developing first or better therapeutic solutions for unmet human medical needs. APSIS small molecule drug discovery programs are based on our growing libraries of modified nucleosides and nucleotides, and our new prodrug technolog y for better drug efficacy, low toxicity, and cell specific delivery. APSIS owns proprietary bc Protide TM prodrug technology ensuring that the active agent is being efficiently generated within the diseased cells (tumors and infected cells) from its prodrugs. APSIS owns proprietary oligonucleotide-protein gene cleaving complexes ( Cas9- lg RNA TM ) technology targeting viral DNAs for curing latent, chronic and relapsing viral infections. To Better Lives with our Sciences APSIS Therapeutics, INC. PO Box 421523 San Francisco, |
HTTP Headers
HTTP/1.1 200 OK Date: Tue, 10 May 2022 08:28:03 GMT Server: Apache Upgrade: h2,h2c Connection: Upgrade Last-Modified: Sun, 07 Apr 2019 01:18:44 GMT Accept-Ranges: bytes Content-Length: 34206 Vary: Accept-Encoding host-header: c2hhcmVkLmJsdWVob3N0LmNvbQ== Content-Type: text/html |
apsisglobal.com Whois Information
Domain Name: APSISGLOBAL.COM Registry Domain ID: 1620451187_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.fastdomain.com Registrar URL: http://www.fastdomain.com Updated Date: 2021-09-30T04:29:42Z Creation Date: 2010-10-15T04:29:18Z Registry Expiry Date: 2022-10-15T04:29:18Z Registrar: FastDomain Inc. Registrar IANA ID: 1154 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.BLUEHOST.COM Name Server: NS2.BLUEHOST.COM DNSSEC: unsigned >>> Last update of whois database: 2022-05-10T09:52:02Z <<< |